Brian Dorsey, Chief Operating Officer at ARS Pharmaceuticals, Inc. (SPRY), sold 40,000 shares at $12.43 ($494K) on 2024-12-11, disclosed to the SEC on 2024-12-13.
Scheduled sale ($494k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.43 | 15,000 | $186K | 37.7% |
| 2 | $12.30 | 25,000 | $308K | 62.3% |
| Total | $12.35 avg | 40,000 | $494K | 100% |
| Filing → |
| SPRY | SELL | 2024-08-15 | $390K | — | Filing → |
| APRI | BUY | 2014-12-30 | $11K | — | Filing → |
| SOMX | SELL | 2012-01-04 | $4K | — | Filing → |